Literature DB >> 3243553

Genotyping and sequence analysis of apolipoprotein E isoforms.

M Emi1, L L Wu, M A Robertson, R L Myers, R A Hegele, R R Williams, R White, J M Lalouel.   

Abstract

Apolipoprotein E (apoE), a polymorphic plasma protein, is essential for catabolism of lipoproteins by receptor-mediated endocytosis. One of the apoE isoforms (E2) differs in its binding affinity to specific receptors and contributes to variations in lipoprotein metabolism. Diagnosis of apoE isoforms is done by isoelectric focusing, but it is hindered by various degrees of post-translational sialylation of the apoE protein. Electrophoretically silent structural variations may also escape detection by this technique. We describe a method for genotyping apoE based on hybridization of allele-specific oligonucleotides with enzymatically amplified genomic DNA, which permits unambiguous diagnosis of six common apoE phenotypes within 24 h. Among 100 E2 alleles present in 81 unrelated individuals genotyped by this technique, we found two rare structural mutants of apoE in addition to the common E2 form, E2(158Arg----Cys). Automated sequencing of amplified DNA identified the rare mutants as E2(136Arg----Ser) and E2(145Arg----Cys). The genotypic method may complement or even replace isoelectric focusing for routine determination of apoE phenotypes and for identification of rare structural variants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3243553     DOI: 10.1016/0888-7543(88)90130-9

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  66 in total

1.  Detection of single base differences using biotinylated nucleotides with very long linker arms.

Authors:  K J Livak; F W Hobbs; R J Zagursky
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

2.  Fruit and vegetable juices and Alzheimer's disease: the Kame Project.

Authors:  Qi Dai; Amy R Borenstein; Yougui Wu; James C Jackson; Eric B Larson
Journal:  Am J Med       Date:  2006-09       Impact factor: 4.965

3.  Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.

Authors:  E Boerwinkle; S A Brown; K Rohrbach; A M Gotto; W Patsch
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

4.  Free left arms as precursor molecules in the evolution of Alu sequences.

Authors:  J Jurka; E Zuckerkandl
Journal:  J Mol Evol       Date:  1991-07       Impact factor: 2.395

5.  Atrial fibrillation and risk of dementia: a prospective cohort study.

Authors:  Sascha Dublin; Melissa L Anderson; Sebastien J Haneuse; Susan R Heckbert; Paul K Crane; John C S Breitner; Wayne McCormick; James D Bowen; Linda Teri; Susan M McCurry; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2011-08-01       Impact factor: 5.562

Review 6.  Application of the polymerase chain reaction to the diagnosis of human genetic disease.

Authors:  J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

7.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

8.  Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.

Authors:  Simona Vuletic; Ge Li; Elaine R Peskind; Hal Kennedy; Santica M Marcovina; James B Leverenz; Eric C Petrie; Virginia M-Y Lee; Douglas Galasko; Gerard D Schellenberg; John J Albers
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

9.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

Authors:  James B Leverenz; Mark A Fishel; Elaine R Peskind; Thomas J Montine; David Nochlin; Ellen Steinbart; Murray A Raskind; Gerard D Schellenberg; Thomas D Bird; Debby Tsuang
Journal:  Arch Neurol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.